We have succeeded in particapating 2018 Shanghai CPHI--Wuhan Sunrise Technology

中文版　英文版

Product Categories

Ophthalmology Series APIs
Monoclonal Antibody APIs
More competitive intermedites
Cell culture medium

5-Bromoacetyl-2-hydroxybenzaldehyde

6-N-Benzylamino-1-(4’-phenylbutoxy)Hexane

(E)-6-Iodo-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole

N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-yl]thio]benzamide

News

We have succeeded in particapating 2018 Shanghai CPHI

2018-06-25

During this 2018 Shanghai CPHI , we have succeeded in meeting and taking ccoperation with new and old customers from India, Bangladesh, Pakistan , Russia , Iran , Brazil , Argentina and so on.